12:21 PM EST - Cognetivity Neurosciences Ltd : Announces that it has entered into a collaborative arrangement with PRIME Health, which is one of the United Arab Emirates' leading healthcare service providers with Multi-speciality Hospital, multiple clinics, Pharmacies and diagnostic centres. Cognetivity has successfully demonstrated its Integrated Cognitive Assessment tool to Prime stakeholders and will provide CognICA for a clinic-based pilot project that is ultimately designed to integrate Cognetivity's tablet-based application into Prime's suite of corporate client services across the UAE. Cognetivity Neurosciences Ltd
shares C.CGN are trading unchanged at $0.36.
